Kowa Pharmaceuticals America

Focused on protecting vision.
Driven to improve lives.

At Kowa Pharmaceuticals America, Inc., we are re-envisioning eye care, preserving vision, and pioneering what's next, for every eye and every patient.

Eye graphic representing Kowa's focus on protecting and preserving vision.

Backed by global expertise in eye care

Kowa Pharmaceuticals America, Inc. is part of a broader global network dedicated to ocular health. Within the Kowa group of companies, our U.S. pharmaceutical business works alongside the ophthalmic and medical equipment division to support eye care providers with both prescription therapies and diagnostic technologies.

Our portfolio reflects both our heritage and our future

Today, we offer marketed products that help manage cardiometabolic risk while we expand into ophthalmology, with a pipeline designed to support long-term ocular health and vision preservation.

Opportunity to make an impact

Our team is united by a belief that doing things with passion leads to better outcomes for patients, providers, and communities. If you are a visionary passionate about improving health and advancing eye care, explore open roles across our corporate and field organizations.

Explore Our Opportunities
Kowa office team

Recent news

FEBRUARY 10, 2026

Nicox to Present Data from NCX 470 Phase 3 Studies at American Glaucoma Society (AGS) Annual Meeting 2026

AUGUST 21, 2025

Nicox Announces Positive Results from the NCX 470 Phase 3 Denali Trial in Glaucoma Patients

AUGUST 5, 2025

Nicox’s Partner Kowa Initiates NCX 470 Phase 3 Clinical Trial in Japan